KKR (NYSE: KKR) announced the signing of a definitive agreement to acquire ReSearch Pharmaceutical Services Inc. (“RPS”), a leading global ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE